These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 25516122)
41. Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia. Santini MA; Ratner C; Aznar S; Klein AB; Knudsen GM; Mikkelsen JD J Neurosci Res; 2013 May; 91(5):634-41. PubMed ID: 23404493 [TBL] [Abstract][Full Text] [Related]
42. Dysregulated corticostriatal activity in open-field behavior and the head-twitch response induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine. Rangel-Barajas C; Estrada-Sánchez AM; Barton SJ; Luedtke RR; Rebec GV Neuropharmacology; 2017 Feb; 113(Pt A):502-510. PubMed ID: 27816502 [TBL] [Abstract][Full Text] [Related]
43. Age-related loss of responsiveness to 2,5-dimethoxy-4-iodoamphetamine in liver sinusoidal endothelial cells. Cogger VC; Mitchell SJ; Warren A; de Cabo R; Le Couteur DG J Gerontol A Biol Sci Med Sci; 2014 May; 69(5):514-8. PubMed ID: 23974079 [TBL] [Abstract][Full Text] [Related]
44. Exhibition of Cast of Fœtal Head. Macdonald Trans Edinb Obstet Soc; 1879; 5():25. PubMed ID: 29612818 [No Abstract] [Full Text] [Related]
45. Endocannabinoid signalling and the deteriorating brain. Di Marzo V; Stella N; Zimmer A Nat Rev Neurosci; 2015 Jan; 16(1):30-42. PubMed ID: 25524120 [TBL] [Abstract][Full Text] [Related]
46. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia. Gomes FV; Guimarães FS; Grace AA Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381 [TBL] [Abstract][Full Text] [Related]
47. Severe motor and vocal tics controlled with Sativex®. Trainor D; Evans L; Bird R Australas Psychiatry; 2016 Dec; 24(6):541-544. PubMed ID: 27558217 [TBL] [Abstract][Full Text] [Related]
48. Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2. Fanarioti E; Mavrikaki M; Panagis G; Mitsacos A; Nomikos GG; Giompres P Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522428 [TBL] [Abstract][Full Text] [Related]
49. Active endocannabinoids are secreted on extracellular membrane vesicles. Gabrielli M; Battista N; Riganti L; Prada I; Antonucci F; Cantone L; Matteoli M; Maccarrone M; Verderio C EMBO Rep; 2015 Feb; 16(2):213-20. PubMed ID: 25568329 [TBL] [Abstract][Full Text] [Related]
50. Pharmacological modulation of abnormal involuntary DOI-induced head twitch response movements in male DBA/2J mice: II. Effects of D3 dopamine receptor selective compounds. Rangel-Barajas C; Malik M; Mach RH; Luedtke RR Neuropharmacology; 2015 Jun; 93():179-90. PubMed ID: 25698528 [TBL] [Abstract][Full Text] [Related]
51. Toward sophisticated basal ganglia neuromodulation: Review on basal ganglia deep brain stimulation. Da Cunha C; Boschen SL; Gómez-A A; Ross EK; Gibson WS; Min HK; Lee KH; Blaha CD Neurosci Biobehav Rev; 2015 Nov; 58():186-210. PubMed ID: 25684727 [TBL] [Abstract][Full Text] [Related]
52. The role of AMP-activated protein kinase in the androgenic potentiation of cannabinoid-induced changes in energy homeostasis. Borgquist A; Meza C; Wagner EJ Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E482-95. PubMed ID: 25550281 [TBL] [Abstract][Full Text] [Related]
53. Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses. Batista LA; Bastos JR; Moreira FA J Psychopharmacol; 2015 Mar; 29(3):335-43. PubMed ID: 25601395 [TBL] [Abstract][Full Text] [Related]
54. Preliminary Evidence on Cannabis Effectiveness and Tolerability for Adults With Tourette Syndrome. Abi-Jaoude E; Chen L; Cheung P; Bhikram T; Sandor P J Neuropsychiatry Clin Neurosci; 2017; 29(4):391-400. PubMed ID: 28464701 [TBL] [Abstract][Full Text] [Related]
55. A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome. Bowles NP; Karatsoreos IN; Li X; Vemuri VK; Wood JA; Li Z; Tamashiro KL; Schwartz GJ; Makriyannis AM; Kunos G; Hillard CJ; McEwen BS; Hill MN Proc Natl Acad Sci U S A; 2015 Jan; 112(1):285-90. PubMed ID: 25535367 [TBL] [Abstract][Full Text] [Related]
56. Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects. Sadhasivam S; Zhang X; Chidambaran V; Mavi J; Pilipenko V; Mersha TB; Meller J; Kaufman KM; Martin LJ; McAuliffe J Pharmacogenomics J; 2015 Oct; 15(5):436-42. PubMed ID: 25558980 [TBL] [Abstract][Full Text] [Related]
57. Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. Gray JM; Vecchiarelli HA; Morena M; Lee TT; Hermanson DJ; Kim AB; McLaughlin RJ; Hassan KI; Kühne C; Wotjak CT; Deussing JM; Patel S; Hill MN J Neurosci; 2015 Mar; 35(9):3879-92. PubMed ID: 25740517 [TBL] [Abstract][Full Text] [Related]
58. N-acyl dopamine derivates as lead compound for implementation in transplantation medicine. Wedel J; Pallavi P; Stamellou E; Yard BA Transplant Rev (Orlando); 2015 Jul; 29(3):109-13. PubMed ID: 25576467 [TBL] [Abstract][Full Text] [Related]
59. Chronic stress induces anxiety via an amygdalar intracellular cascade that impairs endocannabinoid signaling. Qin Z; Zhou X; Pandey NR; Vecchiarelli HA; Stewart CA; Zhang X; Lagace DC; Brunel JM; Béïque JC; Stewart AF; Hill MN; Chen HH Neuron; 2015 Mar; 85(6):1319-31. PubMed ID: 25754825 [TBL] [Abstract][Full Text] [Related]
60. 13-year-old girl with recurrent, episodic, persistent vomiting: out of the pot and into the fire. Felton D; Zitomersky N; Manzi S; Lightdale JR Pediatrics; 2015 Apr; 135(4):e1060-3. PubMed ID: 25733759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]